{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:05:30Z","timestamp":1784761530788,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["UID 41744"],"award-info":[{"award-number":["UID 41744"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["004 94525"],"award-info":[{"award-number":["004 94525"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015566","name":"EDF Energy Research and Development","doi-asserted-by":"publisher","award":["93360"],"award-info":[{"award-number":["93360"]}],"id":[{"id":"10.13039\/100015566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004513","name":"Harry Crossley Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"The Francis Crick Institute","doi-asserted-by":"publisher","award":["MR\/P028071\/1"],"award-info":[{"award-number":["MR\/P028071\/1"]}],"id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016962","name":"Department of Science and Innovation, South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacig.2025.100540","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T23:34:13Z","timestamp":1753313653000},"page":"100540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical recommendations for diagnosis and management of Mendelian susceptibility to mycobacterial disease in resource-limited settings"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1855-690X","authenticated-orcid":false,"given":"Helena","family":"Cornelissen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Glanzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansia","family":"van Coller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Glashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omaima","family":"Abdelmajeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Erwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2025.100540_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib3","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2014-06-583260","article-title":"Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment","volume":"124","author":"Seidel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jacig.2025.100540_bib4","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2025.100540_bib5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.emboj.7601558","article-title":"Human genetics of infectious diseases: a unified theory","volume":"26","author":"Casanova","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.jacig.2025.100540_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/imcb.12210","article-title":"Mendelian susceptibility to mycobacterial disease: 2014\u20132018 update","volume":"97","author":"Rosain","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jacig.2025.100540_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/10408363.2018.1444580","article-title":"Laboratory evaluation of the IFN-\u03b3 circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease","volume":"55","author":"Esteve-Sol\u00e9","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jacig.2025.100540_bib8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.7196\/SAMJ.2021.v111i10.15341","article-title":"Mendelian susceptibility to mycobacterial disease in tuberculosis-hyperendemic South Africa","volume":"111","author":"Cornelissen","year":"2021","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jacig.2025.100540_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12865-021-00452-6","article-title":"Phenotypic and immune functional profiling of patients with suspected Mendelian susceptibility to mycobacterial disease in South Africa","volume":"22","author":"van Coller","year":"2021","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib11","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.cmi.2022.03.004","article-title":"Mendelian susceptibility to mycobacterial diseases: state of the art","volume":"28","author":"Noma","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jacig.2025.100540_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7196\/SAMJ.2019.v109i8b.13820","article-title":"Primary immunodeficiency in Africa\u2014a review","volume":"109","author":"Erjaee","year":"2019","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jacig.2025.100540_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-012-9751-7","article-title":"Primary immunodeficiency diseases worldwide: more common than generally thought","volume":"33","author":"Bousfiha","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41435-018-0041-0","article-title":"Primary immunodeficiency diseases in a tuberculosis endemic region: challenges and opportunities","volume":"20","author":"Glanzmann","year":"2019","journal-title":"Genes Immun"},{"key":"10.1016\/j.jacig.2025.100540_bib15","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.7196\/SAMJ.8946","article-title":"Investigation and management of primary immunodeficiency in South African children","volume":"104","author":"Eley","year":"2014","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jacig.2025.100540_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.926781","article-title":"An updated review on MSMD research globally and a literature review on the molecular findings, clinical manifestations, and treatment approaches in China","volume":"13","author":"Xia","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0018-2016","article-title":"Cytokines and chemokines in Mycobacterium tuberculosis infection","volume":"4","author":"Domingo-Gonzalez","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jacig.2025.100540_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jacig.2025.100540_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1080416","article-title":"Interferon gamma\/NADPH oxidase defense system in immunity and cancer","volume":"5","author":"Hodny","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jacig.2025.100540_bib20","doi-asserted-by":"crossref","first-page":"E7128","DOI":"10.1073\/pnas.1521651112","article-title":"Severe infectious diseases of childhood as monogenic inborn errors of immunity","volume":"112","author":"Casanova","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacig.2025.100540_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.2011.06273.x","article-title":"Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases","volume":"1246","author":"Bustamante","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jacig.2025.100540_bib22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaci.2008.10.037","article-title":"The genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases","volume":"122","author":"Al-Muhsen","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib23","article-title":"Mendelian susceptibility to mycobacterial disease: 2014-2018 update","author":"Rosain","year":"2018","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/j.jacig.2025.100540_bib24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00439-020-02126-6","article-title":"The monogenic basis of human tuberculosis","volume":"139","author":"Boisson-Dupuis","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacig.2025.100540_bib25","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1172\/JCI135460","article-title":"Inherited human IFN-\u03b3 deficiency underlies mycobacterial disease","volume":"130","author":"Kerner","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacig.2025.100540_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41577-023-00933-2","article-title":"Anti-cytokine autoantibodies: mechanistic insights and disease associations","volume":"24","author":"Cheng","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib27","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI19316","article-title":"Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma","volume":"115","author":"Kampmann","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacig.2025.100540_bib28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.imbio.2012.08.281","article-title":"Patients with inhibitory and neutralizing auto-antibodies to interferon-\u03b3 resemble the sporadic adult-onset phenotype of Mendelian susceptibility to mycobacterial disease (MSMD) lacking bacille Calmette-Guerin (BCG)-induced diseases","volume":"218","author":"Lee","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.jacig.2025.100540_bib29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00439-020-02180-0","article-title":"Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?","volume":"139","author":"Ku","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacig.2025.100540_bib30","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib31","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jacig.2025.100540_bib32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S1473-3099(15)00089-4","article-title":"Host susceptibility to non-tuberculous mycobacterial infections","volume":"15","author":"Wu","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jacig.2025.100540_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/pathogens13030203","article-title":"Diagnosis and management of infections in patients with Mendelian susceptibility to mycobacterial disease","volume":"13","author":"Dalvi","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.jacig.2025.100540_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccm.2023.07.002","article-title":"Host susceptibility to nontuberculous mycobacterial pulmonary disease","volume":"44","author":"Namkoong","year":"2023","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jacig.2025.100540_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1399-0004.2010.01510.x","article-title":"Mendelian susceptibility to mycobacterial disease","volume":"79","author":"Cottle","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacig.2025.100540_bib36","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s10875-013-9901-6","article-title":"A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside","volume":"33","author":"Bousfiha","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib37","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.3390\/jcm13154435","article-title":"Diagnosis of chronic granulomatous disease: strengths and challenges in the genomic era","volume":"13","author":"O\u2019Donovan","year":"2024","journal-title":"JCM"},{"key":"10.1016\/j.jacig.2025.100540_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmi.2017.06.029","article-title":"Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti\u2013interferon-\u03b3 autoantibodies in patients with disseminated nontuberculous mycobacterial infection","volume":"24","author":"Wu","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jacig.2025.100540_bib39","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/1521-4141(200203)32:3<693::AID-IMMU693>3.0.CO;2-Q","article-title":"Requirement for both IL-12 and IFN-\u03b3 signaling pathways in optimal IFN-\u03b3 production by human T cells","volume":"32","author":"Losana","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10875-016-0244-y","article-title":"Deletion of the entire interferon-\u03b3 receptor 1 gene causing complete deficiency in three related patients","volume":"36","author":"de Vor","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2144\/000112800","article-title":"The evolution of tools for protein phosphorylation site analysis: from discovery to clinical application","volume":"44","author":"Bonilla","year":"2008","journal-title":"Biotechniques"},{"key":"10.1016\/j.jacig.2025.100540_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28187","article-title":"Mendelian susceptibility to mycobacterial disease\u2014challenges in hematopoietic stem cell transplantation","volume":"67","author":"Patel","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jacig.2025.100540_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631298","article-title":"Clinical and molecular findings in Mendelian susceptibility to mycobacterial diseases: experience from India","volume":"12","author":"Taur","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib45","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s10875-021-01116-1","article-title":"Outcome of hematopoietic stem cell transplantation in patients with Mendelian susceptibility to mycobacterial diseases","volume":"41","author":"Radwan","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2025.100540_bib46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.omtm.2020.04.002","article-title":"Human lentiviral gene therapy restores the cellular phenotype of autosomal recessive complete IFN-\u03b3R1 deficiency","volume":"17","author":"Hahn","year":"2020","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325001419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829325001419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:11:11Z","timestamp":1762323071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829325001419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2772829325001419"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100540","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical recommendations for diagnosis and management of Mendelian susceptibility to mycobacterial disease in resource-limited settings","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2025.100540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100540"}}